Clinical Trials Browser

Not yet recruiting × Esophageal Squamous Cell Carcinoma × Capecitabine × Clear all

NCT07251062 2025-11-26

A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

Phase 2/3 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma